title: Response to the commentary 'Pooled indices to measure rheumatoid arthritis activity: a good reflection of the physician's mind'.
authors.forename: Bert
authors.initials: B
authors.lastname: Vander Cruyssen
authors.forename: Patrick
authors.initials: P
authors.lastname: Durez
authors.forename: Rene
authors.initials: R
authors.lastname: Westhovens
authors.forename: Nathan
authors.initials: N
authors.lastname: Vastesaeger
authors.forename: Anja
authors.initials: A
authors.lastname: Geldhof
authors.forename: Filip
authors.initials: F
authors.lastname: De Keyser
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D015415:Biomarkers / Q000032:analysis; D001799:Blood Sedimentation; D006801:Humans; D000069285:Infliximab; D010820:Physicians; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D015415:Biomarkers; D000069285:Infliximab